Want to change something on this page or create your own? Register today, it's fast and free!
Ed Kennedy's practice involves all aspects of federal and international taxation, including mergers and acquisitions, debt instruments and derivatives, foreign currency, Subpart F planning including contract manufacturing, cross-border structured finance, and distressed M&A. Ed works with strategic investors, private equity groups, and hedge funds to structure their investments in the most tax-efficient manner. He also works with large U.S.-based multinational corporations and foreign entities making inbound investments in the U.S., including investments in stock, securities, partnerships, and real estate. He is co-leader of the Firm's global Tax Practice.Ed worked on the federal and international tax aspects of the restructuring of both Dana Corporation and Chrysler LLC in chapter 11. Ed played a leading role in structuring Pfizer's $16.6 billion sale of its consumer health care business to Johnson & Johnson. He led the tax team that structured the $2.8 billion acquisition of the ConAgra commodities trading business by a consortium of private equity funds in 2008. Ed recently helped structure Pfizer's joint venture with GlaxoSmithKline to create a new HIV company.